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doi:10.1016/j.ijsu.2011.06.001Skin ﬂaps are a vital tool in plastic surgery and used to treat and
manage a variety of conditions. However, necrosis of distal ﬂap
regions continue to have a high prevalence and often lead to post-
surgical complications such as infection and the need for repeat
surgery. Extracorporeal shock wave therapy (ESWT) has a range of
functions in medicine including lithotripsy in the ﬁeld of urology
and for the treatment of musculoskeletal disorders.1 The potential
role of ESWT in improving skin ﬂap survival has now been explored
by several studies in animal models.2e10
Meirer and colleagues were the ﬁrst to indicate a use for ESWT
in the maintenance of skin ﬂap viability. Epigastric skin ﬂaps were
raised on Wistar rats with application of ESWT immediately post-
surgery.2 This was shown to signiﬁcantly reduce the total necrotic
zones found compared with the control group. Similarly there was
an increase in VEGF expression within this study.
Recently, Keil et al. showed preoperative exposure of the ﬂap
segment to ESWT was successful in increasing tissue survival.3
A single ESWT exposure, seven days prior to ﬂap retrieval
increased the area of surviving tissue compared with the control
group; this builds on the results of a previous study.4 Direct visu-
alisation of increased micro-vessel density was observed following
ESWT, this was associated with a rise in VEGF to total protein ratio
within the ﬂap. Both these markers indicate an increased likelihood
of ﬂap survival.3 This increase in vascular density may open
a potential therapeutic avenue for ESWT in the treatment of
vascular conditions for example associated with Diabetes
Mellitus.12
This technique has been further expanded by the work exam-
ining the use of repeated ESWT on skin ﬂaps both concomitantlyF. Camm).
ciates Ltd. Published by Elsevier Ltand post-operatively.5,6 Both studies exposed groups to ESWT
either immediately post-operatively, one day post-operatively or
both. These studies similarly support an increase in average ﬂap
area survival following peri-operatiave ESWT. However, there was
no signiﬁcant additional beneﬁt within the group exposed to ESWT
on both occasions.5,6 VEGF and proliferating cell nuclear antigen
expression were increased following ESWT; similarly there was
a decrease in tumour necrosis factor alpha expression.5 These
results indicate that along with increasing vascular proliferation,
ESWT may decrease inﬂammatory responses and apoptosis
following tissue ﬂap transplantation.
It has been further demonstrated that ESWT may also improve
survival of skin ﬂaps through initial vasodilatation prior to
increasing the production of VEGF within the ﬂap.7 This was shown
using laser doppler ﬂowmetry showing increased blood perfusion
within the skin ﬂap of rats exposed to ESWT. This was further
conﬁrmed through irrigation of the microvasculature with india
ink. This process provides for a mechanism by which tissue pres-
ervation occurs prior to the longer term effects of VEGF on vessel
density.
The timing of ESWT to provide optimum effect has been ana-
lysed.8 There was no signiﬁcant difference between application of
ESWT seven days pre-operatively compared with immediately
post-operatively. Application of ESWT both pre- and immediately
post-operatively showed no cumulative effect above that already
seen following a single exposure. Similarly it has been shown that
damage to tissue following ischaemic insult is decreased following
ESWT; this occurs following application pre-, peri- or post-
operatively.9
The optimum number of impulses and their distribution needs
to be examined further. Work by Pietramaggiori et al has shown
how cyclical tension on rat ear led to greater vascularity compared
with static tension11; could a similar effect extend to ESWT?d. All rights reserved.
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DISCUSSIONKamelger et al have shown that shock wave doses between 500 and
2500 impulses were effective at decreasing tissue necrosis.10
However, they were not able to isolate a speciﬁc dosing regimen
that optimises survival. An upper threshold was established; doses
over 5000 impulses showed a decreased effect on tissue survival
and were not signiﬁcantly different to control values.
The mechanism of action by which ESWT operates still requires
elucidation. Importantly the role of ESWT in inﬂuencing signalling
pathways within the cell along with transcription, translation and
gene regulation must be established. Are speciﬁc molecular targets
selectively responsive to certain patterns of ESWT? How does
ESWT interact with ischemic preconditioning, hyperthermia,
hypothermia, drugs, mitogenic and other growth factors? How do
different ﬂap types react to ESWT? Ongoing research into the
potential role of ESWT in central and peripheral vascular disease
may provide a rich corpora of data and potential translational
opportunities that the Plastic Surgeon should keep abreast of.12e16
The cumulative evidence provided by these studies suggests the
use of ESWT may provide an effective method for increasing tissue
viability. Given the presence of this technology within the hospital
environment this could potentially provide an easily implemented
and cost effective strategy. However, much further research is
required to address the questions we have raised.
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